Short Decsription
Creative Biolabs offers HEK293T-Tg(Human Gα16//Human GPR35 (short form) Receptor) Division-Arrested Cell which GPR35 (short form) receptor stably expressed in HEK293T cells which overexpress Gα16.
Description
HEK293T-Tg(Human Gα16//Human GPR35 (short form) Receptor) Division-Arrested Cell was engineered to express the receptor human GPR35 (short form) (NM_005301) and Gα16 gene. This cell line can be used to study GPR35 receptor function, signaling pathways, and potential therapeutic interventions. Dividing-arrest cells are cells that are normally kept under specific culture conditions or treated with agents that prevent cell division from being held in a non-dividing state. This can be achieved through methods such as serum starvation, chemical inhibitors of cell cycle progression, or genetic modification.
Features
Well-characterized stable cell lines;
for cell-based high-throughput screening;
Low-cost evaluation of stable cell lines or limited quantities of compounds.
Applications
GPR35 receptor function, signaling pathways, and potential therapeutic interventions.
Protein Target
GPCR
Receptor Name
GPR35 (short form)
Receptor Family
Orphan
Species
Human
Parental Cell Line
HEK293T Gα16
Transfection
Expression vector containing full-length human GPR35 cDNA (GenBank Accession Number NM_005301) with FLAG tag sequence at N-terminus
Gene
NM_005301
Background
GPR35 is an orphan receptor and expressed in various tissues including stomach, gastrointestinal tissues, and several types of immune cells. Up- regulation of GPR35 has been found in human mast cells upon stimulation with IgE antibodies, human macrophages treated with the environmental contaminant polycyclic aromatic hydrocarbon benzo[a]pyrene, failing heart cells, and gastric cancer cells. Known agonists of the orphan receptor GPR35 are kynurenic acid, zaprinast, 5-nitro-2-(3-phenylproplyamino) benzoic acid, and lysophosphatidic acids.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.